Amdocs (NASDAQ:DOX) Insider Shimie Hortig Sells 5,642 Shares of Company Stock

Amdocs Limited (NASDAQ:DOX – Get Free Report) insider Shimie Hortig sold 5,642 shares of the business’s stock in a transaction dated Saturday, November 14th. The shares were sold at an average price of $43.34, for a total value of $244,524.28. Following the completion of the transaction, the insider owned 185,671 shares in the company, valued at $8,046,981.14. The trade was a 2.95% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Shimie Hortig also recently made the following trade(s):

  • On Sunday, November 15th, Shimie Hortig sold 7,255 shares of Amdocs stock. The stock was sold at an average price of $43.34, for a total value of $314,431.70.
  • On Wednesday, November 11th, Shimie Hortig sold 1,733 shares of Amdocs stock. The stock was sold at an average price of $43.14, for a total value of $74,761.62.
  • On Tuesday, November 10th, Shimie Hortig sold 7,264 shares of Amdocs stock. The stock was sold at an average price of $42.18, for a total value of $306,395.52.

Amdocs Stock Down 4.2%

Shares of DOX opened at $40.50 on Friday. The business’s 50 day moving average is $56.06 and its 200 day moving average is $60.20. The company has a market capitalization of $4.37 billion, a PE ratio of 8.67, a price-to-earnings-growth ratio of 1.38 and a beta of 0.42. Amdocs Limited has a 12-month low of $39.96 and a 12-month high of $84.95. The company has a current ratio of 0.94, a quick ratio of 0.94 and a debt-to-equity ratio of 0.23.

Amdocs (NASDAQ:DOX – Get Free Report) last posted its quarterly earnings results on Tuesday, November 3rd. The technology company reported $1.98 EPS for the quarter, hitting analysts’ consensus estimates of $1.98. Amdocs had a return on equity of 20.81% and a net margin of 10.59%. The company had revenue of $1.19 billion for the quarter, compared to analysts’ expectations of $1.19 billion. During the same period in the previous year, the firm earned $1.83 EPS. The firm’s revenue was up 3.8% compared to the same quarter last year. Research analysts expect that Amdocs Limited will post 5.82 earnings per share for the current fiscal year.

Amdocs Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 29th. Stockholders of record on Thursday, December 31st will be given a dividend of $0.5690 per share. The ex-dividend date is Thursday, December 31st. This represents a $2.28 annualized dividend and a dividend yield of 5.6%. Amdocs’s dividend payout ratio (DPR) is presently 48.82%.

Hedge Funds Weigh In On Amdocs

Several institutional investors have recently added to or reduced their stakes in the company. Defiance ETFs LLC boosted its position in shares of Amdocs by 26.9% during the 3rd quarter. Defiance ETFs LLC now owns 168,508 shares of the technology company’s stock valued at $9,635,000 after acquiring an additional 35,675 shares during the last quarter. Advisors Asset Management Inc. purchased a new position in shares of Amdocs in the third quarter valued at $2,484,000. DGS Capital Management LLC grew its holdings in shares of Amdocs by 18.4% in the third quarter. DGS Capital Management LLC now owns 4,725 shares of the technology company’s stock valued at $270,000 after purchasing an additional 735 shares in the last quarter. Integrated Wealth Concepts LLC increased its position in Amdocs by 223.0% in the third quarter. Integrated Wealth Concepts LLC now owns 5,456 shares of the technology company’s stock worth $312,000 after purchasing an additional 3,767 shares during the last quarter. Finally, Ruffer LLP increased its position in Amdocs by 17.6% in the third quarter. Ruffer LLP now owns 136,517 shares of the technology company’s stock worth $7,793,000 after purchasing an additional 20,396 shares during the last quarter. Hedge funds and other institutional investors own 92.02% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently commented on the stock. Wall Street Zen downgraded shares of Amdocs from a “buy” rating to a “hold” rating in a report on Saturday, November 7th. Weiss Ratings raised shares of Amdocs from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, October 23rd. Stifel Nicolaus reduced their price target on shares of Amdocs from $71.00 to $46.00 and set a “buy” rating on the stock in a report on Wednesday, November 4th. Oppenheimer cut shares of Amdocs from an “outperform” rating to a “market perform” rating in a research note on Wednesday, November 4th. Finally, Zacks Research cut shares of Amdocs from a “hold” rating to a “strong sell” rating in a research note on Monday, November 9th. Two equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $69.00.

Check Out Our Latest Research Report on Amdocs

Amdocs Company Profile

(Get Free Report)

Amdocs provides software and services to communications and media companies. Its offerings include business and operational support systems for billing, customer management, service delivery and network operations, as well as cloud and digital solutions that help clients modernize their businesses and improve customer experiences. Founded in 1982, Amdocs serves communications and media providers in markets around the world. The company is headquartered in the St. Louis, Missouri, area and is led by President and Chief Executive Officer Shuky Sheffer.

Featured Articles

Insider Buying and Selling by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.